Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Injective

Explore full profile

The blockchain built for finance

New York City, United StatesFounded 2018Fintech
Valuation $100–250M Last recorded · 2026
Revenue $10–50M Latest reported FY
Headcount 100–500 Current team size
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Injective and the history behind them.

At a glance

Founded
2018
Headquarters
New York City, United States
Sector
Fintech
Power Law
Colt$25–100M revenue

Latest news

Press, funding announcements and product moves mentioning Injective.

See all news

Investors

28 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed11 investors entered at this stage

  • Krypital Group
  • QCP Soteria
  • Cadenza
  • BitScale
  • The Cabin Capital
  • Innovating Capital
  • Axia8 Ventures
  • Pantera Capital
  • AU21 Capital
  • PNYX Venture
  • StartX

Series A15 investors entered at this stage

  • Jump Crypto
  • GFS Ventures
  • Evangelion Capital
  • Infinity Capital
  • Mark Cuban Companies
  • Ellipti
  • GravityX Capital
  • ZBS CAPITAL
  • White Palm Ventures
  • QCP Capital
  • Black Edge Capital
  • Black Mamba Ventures
  • BlockTower Capital
  • CMS Holdings
  • #Hashed

Series B and later2 investors entered at this stage

Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · New York City HQ
Book a demo for the full country breakdown
Web traffic by country
57K monthly visits
across markets
🇺🇸 United States10.2%
🇪🇸 Spain9.8%
🏳️ Korea7%
🏳️ Republic of6.3%
🇳🇬 Nigeria6.1%
Top 5 markets shown

Investments and acquisitions

Disclosed deals where Injective was the backer or acquirer, 2021–2024. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

4 deals across Injective's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        Injective's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        4 of 4 deals

        Market sentiment

        Posts on X, past 7 days

        An AI-synthesised read of the highest-engagement posts about Injective on X, ranked by likes and reposts, corporate channels excluded.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Injective on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.